9 May, 2007
FDA approval
Federal Food & Drug AdministrationNeuproParkinson's diseaseAnnouncement0 Comments
0
0
Lynn B. Schramek
Lynn B. Schramek2015-06-15 10:52:132015-06-15 15:01:38FDA approvalThe FDA announces the approval of Neupro, the first skin patch designed to treat symptoms of early Parkinson’s disease. Neupro patches, which are changed daily, deliver rotigotine through the skin. Rotigotine is a member of a class of drugs called dopamine agonists, which mimic dopamine’s effects.
Subscribe
Login
0 Comments
